MCRB
NASDAQ
$5.25
Seres Therapeutics Inc (MCRB)
Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $17 (+223.81%)
Market Cap
$52M
Free Cash Flow Yield
-81.05%
Beta (5Y)
0.94
Price Chart
Valuation
Market Cap$52M
Forward P/E10.26
P/S45.04
P/B2.05
Profitability
Total Revenue (TTM)$1.15M
Gross Profit (TTM)-$52M
EBITDA-$84M
Operating Margin-5840%
EPS-$5.01
Financial Health
Free Cash Flow Yield-81.05%
Growth & Risk
EPS 5Y CAGR-26.82%
Revenue 5Y CAGR-36.47%
FCF 5Y CAGR-15.90%
Beta (5Y)0.94
Sharpe Ratio-0.52